CASI Pharmaceuticals Inc — Quarterly Financial Data (NASDAQ:CASI) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Dividends per share — — Dividend yield % — — Payout ratio % — —

Nachrichten

What Drove CASI Pharmaceuticals' 24% Rise After Hours? - CASI Pharmaceuticals (NASDAQ:CASI)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%

NASDAQ-Delisting: Aktie von CASI Pharmaceuticals bricht ein

CASI Pharmaceuticals stock plunges on Nasdaq delisting notice

Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year?

Are Medical Stocks Lagging Alkermes (ALKS) This Year?

China approves CASI Pharmaceuticals’ CID-103 clinical trial for kidney rejection

NASDAQ gewährt CASI Pharmaceuticals Aufschub – Aktie legt nachbörslich deutlich zu

Casi Pharmaceuticals sichert sich Fristverlängerung für NASDAQ-Listing bis Februar 2026

CASI Pharmaceuticals stock surges after Nasdaq grants listing extension

Casi Pharmaceuticals secures Nasdaq listing extension until February 2026

CASI Pharmaceuticals secures $20 million funding for transplant rejection study